National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government Patent Portfolio Statistics

tip_user1

National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government look like?

Total Applications:	35,070
Granted Patents:	21,775
Grant Index	67.4 %
Abandoned/Rejected Applications:	10,534 (32.6%)
In-Process Applications:	2,756
Average Grant Time:	3.39 Years
Average Office Actions:	2.07

Which Technology Area National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government is filing most patents in? (Last 10 years)

Art Unit	Definition	Total Applications
1644	Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology	1,204
1648	Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology	1,151
1634	Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry	1,144
1633	Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry	1,120
1632	Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry	1,068

How many patents are National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government filing every year?

Year	Total Applications
2022	0*
2021	4*
2020	195
2019	243
2018	844

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government in USPTO?

Publication number: –
Application number: 17/310,432

Abstract:
None

Publication date: –
Applicant: National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government
Inventors: Huijun Yin

Publication number: US20220008060A1
Application number: 17/385,230

Abstract:
Among other things, there is disclosed structure and methods for maintaining access to a location in the body while reducing or eliminating the potential for pulling an access device (e.g. a catheter) back through an opening. An introducer sheath includes a distal indented portion and a balloon, so that once placed in a desired location through tissue, the balloon can be inflated to anchor the sheath against retraction. In particular embodiments, structure and methods for accessing the pericardial cavity via the right atrial appendage are shown.

Publication date: 2022-01-13
Applicant: National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government
Inventors: E Fearnot Neal

Publication number: US20210299239A1
Application number: 17/344,627

Abstract:
The present invention provides the induction of novel Th1 response, the induction of cytotoxic T cells and anti-cancer/anti-allergic activity techniques. Provided is a combination of a CpG oligonucleotide and an STING agonist. Also provided is a composition which contains an STING agonist, can be used as a type-I adjuvant, and is characterized in that the STING agonist is administered together with a CpG oligonucleotide.
Further provided is an anti-cancer agent comprising a CpG oligonucleotide and is characterized in that the CpG oligonucleotide is administered together with an STING agonist. Still further provided is a composition which contains a CpG oligonucleotide and can be used for reducing or eliminating the IgE-inducing activity of an STING agonist.

Publication date: 2021-09-30
Applicant: National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government
Inventors: Burcu Temizoz

How are National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government’s applications performing in USPTO?

Application Number	Title	Status	Art Unit	Examiner
17/310,432	Aromatic Ring Or Heteroaromatic Ring Compounds, Preparation Method Therefor And Medical Use Thereof	–	–	–
17/385,230	Vascular Anchoring Introducer Sheath	–	OPAP	Central, Docket
17/344,627	Novel Th1-Inducing Adjuvant Comprising Combination Of Different Nucleic Acid Adjuvants, And Use Of Same	Docketed New Case – Ready for Examination	OPAP	Central, Docket
17/333,256	Composition For Prophylaxis Or Treatment Of Il-8 Related Diseases	Docketed New Case – Ready for Examination	OPAP	Central, Docket